Amrize Ltd (NYSE:AMRZ – Get Free Report) has received an average recommendation of “Moderate Buy” from the seventeen analysts that are currently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $64.8571.
AMRZ has been the subject of several analyst reports. Vertical Research upgraded shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 target price for the company in a report on Friday, May 1st. Stephens restated an “overweight” rating and set a $65.00 price target on shares of Amrize in a report on Monday, May 18th. JPMorgan Chase & Co. upped their price objective on shares of Amrize from $60.00 to $70.00 and gave the stock an “overweight” rating in a research report on Thursday, March 5th. Wall Street Zen upgraded shares of Amrize from a “sell” rating to a “hold” rating in a research note on Sunday, March 1st. Finally, Wells Fargo & Company dropped their target price on shares of Amrize from $66.00 to $65.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 15th.
Check Out Our Latest Research Report on AMRZ
Insiders Place Their Bets
Hedge Funds Weigh In On Amrize
Several institutional investors have recently added to or reduced their stakes in the stock. MCF Advisors LLC purchased a new position in Amrize in the fourth quarter valued at about $27,000. Basepoint Wealth LLC purchased a new stake in shares of Amrize during the 4th quarter worth approximately $33,000. Laurel Wealth Advisors LLC bought a new stake in shares of Amrize in the 4th quarter worth approximately $34,000. State of Wyoming bought a new stake in shares of Amrize in the 3rd quarter worth approximately $32,000. Finally, Itau Unibanco Holding S.A. lifted its stake in Amrize by 150.0% in the fourth quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock valued at $41,000 after purchasing an additional 450 shares during the last quarter.
Amrize Stock Up 2.1%
Shares of NYSE:AMRZ opened at $55.40 on Friday. The stock has a market cap of $30.64 billion and a price-to-earnings ratio of 26.51. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38. Amrize has a 12-month low of $44.12 and a 12-month high of $65.94. The business’s 50 day moving average is $54.12 and its 200 day moving average is $55.62.
Amrize (NYSE:AMRZ – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.84%. The company had revenue of $2.18 billion during the quarter. The firm’s revenue for the quarter was up 4.7% compared to the same quarter last year. On average, sell-side analysts forecast that Amrize will post 2.76 earnings per share for the current fiscal year.
Amrize Cuts Dividend
The firm also recently declared a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were given a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize’s dividend payout ratio (DPR) is presently 21.05%.
About Amrize
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
See Also
- Five stocks we like better than Amrize
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
